Business
Result of General Meeting
Result of General Meeting.
About this update from Skinbiotherapeutics Plc
[{"type":"text","content":"\n \n \n 31 January 2023\n \n \n SkinBioTherapeutics plc\n \n \n \n \n \n Results of General Meeting\n \n \n \n \n \n \n \n SkinBioTherapeutics plc\n \n (AIM: SBTX or the \"Company\")\n \n announces that at the Company's General Meeting, held yesterday 30 January 2023, all resolutions were duly passed.\n \n \n \n \n \n Details of the proxy votes received on each resolution by the Company's Registrar are set out below:\n \n \n \n \n \n \n \n \n Resolution\n \n \n \n \n \n \n For & Discretionary\n \n \n \n \n \n \n Against\n \n \n \n \n \n \n Withheld\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n Number of votes\n \n \n \n \n \n \n %\n \n \n \n \n \n \n Number of votes\n \n \n \n \n \n \n %\n \n \n \n \n \n \n Number of votes\n \n \n \n \n \n \n %\n \n \n \n \n \n \n \n 1\n \n \n \n \n The Directors' and Auditors' reports and the financial statements for the financial year ended 30 June 2022 be received and adopted\n \n \n \n \n 36,364,572\n \n \n \n \n 99.58%\n \n \n \n \n 117,330\n \n \n \n \n 0.32%\n \n \n \n \n 37,825\n \n \n \n \n 0.10%\n \n \n \n \n \n \n 2\n \n \n \n \n Jeffreys Henry LLP be re-appointed as the auditors of the Company until the next Annual General Meeting of the Company\n \n \n \n \n 36,362,147\n \n \n \n \n 99.57%\n \n \n \n \n 129,755\n \n \n \n \n 0.36%\n \n \n \n \n 27,825\n \n \n \n \n 0.08%\n \n \n \n \n \n \n 3\n \n \n \n \n The Directors be authorised to fix the auditors' remuneration\n \n \n \n \n 36,377,487\n \n \n \n \n 99.61%\n \n \n \n \n 114,415\n \n \n \n \n 0.31%\n \n \n \n \n 27,825\n \n \n \n \n 0.08%\n \n \n \n \n \n \n 4\n \n \n \n \n To authorise the directors to allot shares\n \n \n \n \n 36,295,269\n \n \n \n \n 99.39%\n \n \n \n \n 193,322\n \n \n \n \n 0.53%\n \n \n \n \n 31,136\n \n \n \n \n 0.09%\n \n \n \n \n \n \n 5\n \n \n \n \n Special resolution to authorise the directors to disapply pre-emption rights\n \n \n \n \n 36,257,227\n \n \n \n \n 99.28%\n \n \n \n \n 232,575\n \n \n \n \n 0.64%\n \n \n \n \n 29,925\n \n \n \n \n 0.08%\n \n \n \n \n \n \n 6\n \n \n \n \n Special resolution to authorise the directors to disapply pre-emption rights in relation to an acquisition or other capital investment\n \n \n \n \n 36,310,509\n \n \n \n \n 99.43%\n \n \n \n \n 178,555\n \n \n \n \n 0.49%\n \n \n \n \n 30,663...